Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Cell Cycle and Cell Cycle Checkpoint Deregulations: From Oncogenic Drivers to Therapeutic Targets
Deadline: 30 September 2020
Rare Childhood Malignancy
Deadline: 30 September 2020
Thoracic Cancers
Deadline: 30 September 2020
Bladder Cancers
Deadline: 15 October 2020
The Impact of Extracellular Vesicles in Cancer Progression and Diagnosis
Deadline: 15 October 2020
NK/ILCs in Tumors
Deadline: 15 October 2020
Immunotherapy, Tumor Microenvironment and Survival Signaling
Deadline: 30 October 2020
Molecular Genetics of Breast and Ovary Cancer
Deadline: 31 October 2020
Multimodal Therapy of Upper Gastrointestinal Malignancies
Deadline: 31 October 2020
Hepatocellular Carcinoma
Deadline: 31 October 2020
B Cell Malignancies (including B Cell Lymphoma, Multiple Myeloma and B-CLL)
Deadline: 31 October 2020
The Role of NK and T Cells in Cancer
Deadline: 31 October 2020
of 275

